17 Mid Cap Stocks Hit 52-Week Highs On Friday
A small group of mid-cap stocks reached new peaks, but a closer look reveals very different stories beneath the surface.
Kymera Therapeutics (KYMR) has gained 55.2% over the last month, leading a list of 17 Mid Cap stocks reaching their 52-week highs. The group includes large financials like M&T Bank (MTB), with a market value of about $36.2 billion, and all are outperforming the S&P 500’s +2.4% return over the same period. This raises a critical question for any investor scanning the names below: does the underlying business performance justify the new price peak?
The Full List, Largest First
The table below shows the 10 largest of the 17 names, sorted by market capitalization, with returns over four windows:
- Is CRM Stock Really Broken Or Just On Sale?
- What Could Power The Next Rally In META Stock
- What If the Car Is No Longer the Point For Tesla Stock?
- Palantir Stock’s Profitability Challenges the Market’s Slowdown Fears.
- Micron Stock Looks Transformed. One Number Shows The Old Risk Lingers.
- What Intel Stock’s Data Center Was Saying Before The Surge
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| MTB | $36.2 Bil | 1.8% | 1.4% | 7.5% | 24.5% |
| NTRS | $34.0 Bil | 0.4% | 4.0% | 7.6% | 47.8% |
| ES | $28.1 Bil | 1.2% | 0.5% | 7.8% | 20.2% |
| RF | $26.8 Bil | 1.4% | 2.4% | 8.5% | 31.0% |
| FFIV | $24.4 Bil | 0.0% | 5.5% | 8.9% | 42.4% |
| EXPD | $23.0 Bil | 0.8% | 2.7% | 3.4% | 48.2% |
| SN | $21.6 Bil | 2.6% | 0.8% | 18.8% | 40.4% |
| BBY | $17.4 Bil | 3.5% | 6.2% | 11.7% | 20.6% |
| TIGO | $16.2 Bil | 2.7% | 4.3% | 11.9% | 185.1% |
| ARMK | $15.2 Bil | 0.0% | 2.8% | 7.6% | 36.2% |
Are all new highs built on the same foundation?
Consider the contrast. Northern Trust (NTRS), a company with a market value of about $34.0 billion, is at its yearly high even as its revenue declined 2.7% over the last twelve months. In the same list, Eversource Energy (ES) also reached a new high, but its revenue grew 9.8% over the last year. Eversource carries an operating margin of 22.5% and trades at 16.1 times trailing earnings.
A 52-week high is a starting point, not a conclusion.
Stocks showing strength often continue to do so. But a high price is a fact, not a verdict on a company’s quality or future. The disciplined approach is to treat this list as a signal to investigate further. The essential work begins after reading the names: checking if the business itself earns the level the market has awarded it.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.